Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.200
+0.650 (41.94%)
At close: Feb 27, 2026, 4:00 PM EST
2.130
-0.070 (-3.18%)
After-hours: Feb 27, 2026, 7:59 PM EST
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $18.37 million as of February 27, 2026. Its market cap has increased by 184.75% in one year.
Market Cap
18.37M
Enterprise Value
6.31M
1-Year Change
184.75%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has decreased from $37.12M to $18.37M, a decrease of -50.52%. That is a compound annual growth rate of -9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 18.37M | 55.20% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GT Biopharma | 12.01M |
| Soligenix | 11.90M |
| Akari Therapeutics, | 11.81M |
| BioLineRx | 11.78M |
| Pulmatrix | 11.76M |
| Moolec Science | 11.71M |
| Longeveron | 11.70M |
| KALA BIO | 11.41M |